Hak-Hyun Nam
Oprichter bij I-SENS, INC.
Vermogen: 29 M $ op 30-04-2024
Actieve functies van Hak-Hyun Nam
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
I-SENS, INC. | Directeur/Bestuurslid | 04-05-2000 | - |
Algemeen Directeur | - | - | |
Oprichter | 04-05-2000 | - | |
Hoofd Techniek/Wetenschap/O&O | 04-05-2000 | - | |
President | 31-03-2015 | - | |
PRECISION BIOSENSOR, INC. | Directeur/Bestuurslid | - | - |
I Sense Jiangsu Co., Ltd. | Directeur/Bestuurslid | - | - |
CoaguSense, Inc.
CoaguSense, Inc. Electronic Equipment/InstrumentsElectronic Technology CoaguSense, Inc. operates as a diagnostic device company that develops portable point-of-care prothrombin time and international normalized ratio analyzer to directly detect blood clotting time for patients stabilized on oral anti-coagulation medications. The firm’s product is CoaguSense PT/INR monitoring system which incorporates a novel direct micromechanical clot detection technology. The company was founded in 2008 and is headquartered in Fremont, CA. | Directeur/Bestuurslid | - | - |
Loopbaan van Hak-Hyun Nam
Opleiding van Hak-Hyun Nam
Michigan State University | Doctorate Degree |
Statistieken
Internationaal
Zuid-Korea | 3 |
Verenigde Staten | 3 |
China | 2 |
Operationeel
Director/Board Member | 4 |
Chief Executive Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 2 |
Electronic Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
I-SENS, INC. | Health Technology |
PRECISION BIOSENSOR, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
I Sense Jiangsu Co., Ltd. | |
CoaguSense, Inc.
CoaguSense, Inc. Electronic Equipment/InstrumentsElectronic Technology CoaguSense, Inc. operates as a diagnostic device company that develops portable point-of-care prothrombin time and international normalized ratio analyzer to directly detect blood clotting time for patients stabilized on oral anti-coagulation medications. The firm’s product is CoaguSense PT/INR monitoring system which incorporates a novel direct micromechanical clot detection technology. The company was founded in 2008 and is headquartered in Fremont, CA. | Electronic Technology |
- Beurs
- Insiders
- Hak-Hyun Nam
- Ervaring